Toward in silico CMC: An industrial collaborative approach to model-based process development.

computational fluid dynamics mechanistic modeling molecular modeling plant simulation

Journal

Biotechnology and bioengineering
ISSN: 1097-0290
Titre abrégé: Biotechnol Bioeng
Pays: United States
ID NLM: 7502021

Informations de publication

Date de publication:
12 2020
Historique:
received: 28 05 2020
revised: 26 07 2020
accepted: 27 07 2020
pubmed: 30 7 2020
medline: 4 3 2022
entrez: 30 7 2020
Statut: ppublish

Résumé

The Third Modeling Workshop focusing on bioprocess modeling was held in Kenilworth, NJ in May 2019. A summary of these Workshop proceedings is captured in this manuscript. Modeling is an active area of research within the biotechnology community, and there is a critical need to assess the current state and opportunities for continued investment to realize the full potential of models, including resource and time savings. Beyond individual presentations and topics of novel interest, a substantial portion of the Workshop was devoted toward group discussions of current states and future directions in modeling fields. All scales of modeling, from biophysical models at the molecular level and up through large scale facility and plant modeling, were considered in these discussions and are summarized in the manuscript. Model life cycle management from model development to implementation and sustainment are also considered for different stages of clinical development and commercial production. The manuscript provides a comprehensive overview of bioprocess modeling while suggesting an ideal future state with standardized approaches aligned across the industry.

Identifiants

pubmed: 32725887
doi: 10.1002/bit.27520
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3986-4000

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Baldea, M., Edgar, T. F., Stanley, B. L., & Kiss, A. A. (2017). Modular manufacturing processes: Status, challenges, and opportunities. AIChE Journal, 63(10), 4262-4272.
Benner, S. W., Welsh, J. P., Rauscher, M. A., & Pollard, J. M. (2019). Prediction of lab and manufacturing scale chromatography performance using mini-columns and mechanistic modeling. Journal of Chromatography A, 1593, 54-62. https://doi.org/10.1016/j.chroma.2019.01.063
Bertran, M.-O., Frauzem, R., Sanchez-Arcilla, A.-S., Zhang, L., Woodley, J. M., & Gani, R. (2017). A generic methodology for processing route synthesis and design based on superstructure optimization. Computers & Chemical Engineering, 106, 892-910.
Bieringer, T., Bramslepe, C., Brand, S., Brodhagen, A., Dreiser, C., Fleischer-Trebes, C., & Kockmann, N. (2016). Modular Plants: Flexible Chemical Production by Modularization and Standardization-Status Quo and Future Trends. DECHEMA Gesellschaft für Chemische Technik und Biotechnologie eV.
Briskot, T., Stückler, F., Wittkopp, F., Williams, C., Yang, J., Konrad, S., … Hepbildikler, S. (2019). Prediction uncertainty assessment of chromatography models using Bayesian inference. Journal of Chromatography A, 1587, 101-110.
Carta, G., & Jungbauer, A. (2020). Protein chromatography: Process development and scale-up. Newark, NJ: John Wiley & Sons.
Cavallotti, C., & Salvalaglio, M. (2012). Molecular modelling of the affinity chromatography of proteins. Chimica oggi/Chemistry Today, 30(5).
Coffman, J., Marques, B., Orozco, R., Aswath, M., Mohammad, H., Zimmermann, E., … Willson, R. C. (2020). Highland games: A benchmarking exercise in predicting biophysical and drug properties of monoclonal antibodies from amino acid sequences. Biotechnology and Bioengineering, 117(7), 2100-2115. https://doi.org/10.1002/bit.27349
Dhanasekharan, K. M., Sanyal, J., Jain, A., & Haidari, A. (2005). A generalized approach to model oxygen transfer in bioreactors using population balances and computational fluid dynamics. Chemical Engineering Science, 60(1), 213-218.
Hagel, L. (2011). Gel filtration: Size exclusion chromatography. In J.-C. Janson (Ed.), Protein purification: Principles, high resolution methods, and applications (pp. 51-91). Hoboken, NJ: John Wiley & Sons.
Hahn, T., Huuk, T., Osberghaus, A., Doninger, K., Nath, S., Hepbildikler, S., … Hubbuch, J. (2016). Calibration-free inverse modeling of ion-exchange chromatography in industrial antibody purification. Engineering in Life Sciences, 16(2), 107-113.
Hansen, E. B. (2017). Chromatographic scale-up on a volume basis. In A. Staby, A. S. Rathore & S. Ahuja (Eds.), Preparative chromatography for separation of proteins (p. 227). Hoboken, NJ: John Wiley & Sons.
Haringa, C., Tang, W., Wang, G., Deshmukh, A. T., van Winden, W. A., Chu, J., … Noorman, H. J. (2018). Computational fluid dynamics simulation of an industrial P. chrysogenum fermentation with a coupled 9-pool metabolic model: Towards rational scale-down and design optimization. Chemical Engineering Science, 175, 12-24.
Harjunkoski, I., Maravelias, C. T., Bongers, P., Castro, P. M., Engell, S., Grossmann, I. E., … Wassick, J. (2014). Scope for industrial applications of production scheduling models and solution methods. Computers & Chemical Engineering, 62, 161-193.
Hunt, S., Larsen, T., & Todd, R. J. (2017). Modeling preparative cation exchange chromatography of monoclonal antibodies. In A. Staby, A. S. Rathore & S. Ahuja (Eds.), Preparative chromatography for separation of proteins (p. 399). Hoboken, NJ: John Wiley & Sons.
ICH Q8(R2): Pharmaceutical development. (2009).
ICH Q9: Quality risk management. (2005).
ICH Q10: Pharmaceutical quality system. (2008).
ICH Q11: Development and manufacture of drug substances (chemical entities and biotechnological/biological entities). (2012).
Ladd Effio, C., Hahn, T., Seiler, J., Oelmeier, S. A., Asen, I., Silberer, C., … Hubbuch, J. (2016). Modeling and simulation of anion-exchange membrane chromatography for purification of Sf9 insect cell-derived virus-like particles. Journal of Chromatography A, 1429, 142-154. https://doi.org/10.1016/j.chroma.2015.12.006
LaRoche, R. D. (2005). Biopharmaceutical scale-up and scale-down using fluid mixing analysis and computational fluid dynamics (CFD). Paper presented at the 2005 AIChE Annual Meeting, Cincinatti, OH.
Leweke, S., & von Lieres, E. (2018). Chromatography analysis and design toolkit (CADET). Computers & Chemical Engineering, 113, 274-294.
Liderfelt, J., & Royce, J. (2018). Filtration principles. In G. Jagschies, E. Lindskog, K. Lacki & P. Galliher (Eds.), Biopharmaceutical processing: Development, design, and implementation of manufacturing processes (pp. 279-293). Cambridge, MA: Elsevier.
Rischawy, F., Saleh, D., Hahn, T., Oelmeier, S., Spitz, J., & Kluters, S. (2019). Good modeling practice for industrial chromatography: Mechanistic modeling of ion exchange chromatography of a bispecific antibody. Computers & Chemical Engineering, 130, 106532.
Rolandi, P. A. (2019). The unreasonable effectiveness of equations: Advanced modeling for biopharmaceutical process development. Proceedings of computer aided chemical engineering (Vol. 47, pp. 137-150). Elsevier.
Sejergaard, L., Hansen, M. H., Olsen, A. A., Ostergaard, P., Strom-Hansen, T., Ostfeldt, P., … Staby, A. (2013). Implementation of unit operation design spaces: Experiences with regulatory authorities. Paper presented at the 245th ACS National Meeting, New Orleans, LA.
Staby, A., Ahuja, S., & Rathore, A. S. (2017). Model-based preparative chromatography process development in the QbD paradigm. In A. Staby, A. S. Rathore & S. Ahuja (Eds.), Preparative chromatography for separation of proteins (p. 1). Hoboken, NJ: John Wiley & Sons.
van Reis, R., & Zydney, A. (2007). Bioprocess membrane technology. Journal of Membrane Science, 297(1-2), 16-50.
Wutz, J., Lapin, A., Siebler, F., Schäfer, J. E., Wucherpfennig, T., Berger, M., & Takors, R. (2016). Predictability of kLa in stirred tank reactors under multiple operating conditions using an Euler-Lagrange approach. Engineering in Life Sciences, 16(7), 633-642.

Auteurs

David Roush (D)

Merck & Co., Inc., Kenilworth, New Jersey.

Dilip Asthagiri (D)

Department of Chemical and Biomolecular Engineering, Rice University, Houston, Texas.

Deenesh K Babi (DK)

Novo Nordisk A/S, Bagsvaerd, Denmark.

Steve Benner (S)

Merck & Co., Inc., Kenilworth, New Jersey.

Camille Bilodeau (C)

Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York.

Giorgio Carta (G)

Department of Chemical Engineering, University of Virginia, Charlottesville, Virginia.

Philipp Ernst (P)

Bayer AG, Leverkusen, Germany.

Mark Fedesco (M)

Genentech, Inc., San Francisco, California.

Sean Fitzgibbon (S)

KBI Biopharma, Boulder, Colorado.

Matthew Flamm (M)

Merck & Co., Inc., Kenilworth, New Jersey.

Jan Griesbach (J)

F. Hoffman-La Roche, Basel, Switzerland.

Tobias Grosskopf (T)

Roche Diagnostics GmbH, Penzberg, Germany.

Ernst B Hansen (EB)

Novo Nordisk A/S, Bagsvaerd, Denmark.

Tobias Hahn (T)

Karlsruhe Institute of Technology, Karlsruhe, Germany.

Stephen Hunt (S)

KBI Biopharma, Boulder, Colorado.

Francis Insaidoo (F)

Merck & Co., Inc., Kenilworth, New Jersey.

Abraham Lenhoff (A)

Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware.

Jasper Lin (J)

Genentech, Inc., San Francisco, California.

Henrik Marke (H)

Novo Nordisk A/S, Bagsvaerd, Denmark.

Bruno Marques (B)

Century Therapeutics, Philadelphia, Pennsylvania.

Emmanouil Papadakis (E)

Novo Nordisk A/S, Bagsvaerd, Denmark.

Fabrice Schlegel (F)

Amgen, Inc., Cambridge, Massachusetts.

Arne Staby (A)

Novo Nordisk A/S, Bagsvaerd, Denmark.

Marcel Stenvang (M)

Novo Nordisk A/S, Bagsvaerd, Denmark.

Larry Sun (L)

Amgen, Inc., Cambridge, Massachusetts.

Peter M Tessier (PM)

Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan.

Robert Todd (R)

KBI Biopharma, Boulder, Colorado.

Eric von Lieres (E)

Institute of Bio- and Geosciences 1, Research Centre Julich, Julich, Germany.

John Welsh (J)

Merck & Co., Inc., Kenilworth, New Jersey.

Richard Willson (R)

Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas.

Gang Wang (G)

Boehringer Ingelheim, Ingelheim, Germany.

Thomas Wucherpfennig (T)

Boehringer Ingelheim, Ingelheim, Germany.

Oleksandr Zavalov (O)

Merck & Co., Inc., Kenilworth, New Jersey.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans Meta-Analysis as Topic Sample Size Models, Statistical Computer Simulation
Humans Algorithms Software Artificial Intelligence Computer Simulation
Humans Robotic Surgical Procedures Clinical Competence Male Female

Classifications MeSH